Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05511844 |
Title | Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Orum Therapeutics USA, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama Birmingham | Birmingham | Alabama | 35233 | United States | Details | |
University of California - Los Angeles | Los Angeles | California | 90095 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Washington University | Saint Louis | Missouri | 63110 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Weill Cornell Medicine-New York | New York | New York | 10065 | United States | Details | |
Sarah Cannon Research Institute at Tennessee Oncology | Nashville | Tennessee | 32703 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
NEXT Oncology - Virginia Cancer Specialists | Fairfax | Virginia | 22031 | United States | Details | |
Fred Hutchinson Cancer Center | Seattle | Washington | 98109 | United States | Details |